Trial · NCT02415556
Adverse events280
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 280
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Flu-like symptoms | General disorders | Type 2 Diabetes Mellitus - Insulin | 13 | 51 | 17 |
| other | Flu-like symptoms | General disorders | Type 2 Diabetes Mellitus - Placebo | 11 | 55 | 12 |
| other | Flu-like symptoms | General disorders | Control - Insulin | 8 | 58 | 12 |
| other | Flu-like symptoms | General disorders | Control - Placebo | 17 | 59 | 17 |
| other | Fall | Injury, poisoning and procedural complications | Type 2 Diabetes Mellitus - Insulin | 6 | 51 | 6 |
| other | Fall | Injury, poisoning and procedural complications | Type 2 Diabetes Mellitus - Placebo | 3 | 55 | 4 |
| other | Fall | Injury, poisoning and procedural complications | Control - Insulin | 4 | 58 | 4 |
| other | Fall | Injury, poisoning and procedural complications | Control - Placebo | 4 | 59 | 4 |
| other | Diarrhea | Gastrointestinal disorders | Type 2 Diabetes Mellitus - Insulin | 2 | 51 | 2 |
| other | Diarrhea | Gastrointestinal disorders | Type 2 Diabetes Mellitus - Placebo | 7 | 55 | 8 |
| other | Diarrhea | Gastrointestinal disorders | Control - Insulin | 1 | 58 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Control - Placebo | 1 | 59 | 1 |
| other | Dizziness | Nervous system disorders | Type 2 Diabetes Mellitus - Insulin | 2 | 51 | 2 |
| other | Dizziness | Nervous system disorders | Type 2 Diabetes Mellitus - Placebo | 4 | 55 | 4 |
| other | Dizziness | Nervous system disorders | Control - Insulin | 3 | 58 | 4 |
| other | Dizziness | Nervous system disorders | Control - Placebo | 1 | 59 | 1 |
| other | Hypoglycemia | Metabolism and nutrition disorders | Type 2 Diabetes Mellitus - Insulin | 5 | 51 | 5 |
| other | Hypoglycemia | Metabolism and nutrition disorders | Type 2 Diabetes Mellitus - Placebo | 3 | 55 | 6 |
| other | Hypoglycemia | Metabolism and nutrition disorders | Control - Insulin | 4 | 58 | 4 |
| other | Hypoglycemia | Metabolism and nutrition disorders | Control - Placebo | 4 | 59 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02415556/events